NFKB1 and obesity disorder: Beta-sitosterol ameliorates the IKKβ/NF-κB and c-Jun-N-terminal kinase signaling pathways in the adipose tissue by downregulating inflammatory events, thereby inhibiting obesity-induced insulin resistance [24].